Company: CDT
Filing Date: 2025-04-22
Form Type: S-3
Source: 0001641172-25-005732
Chunk: 18

Company: CDT Equity Inc.
Filing Date: 2025-04-22
Form: S-3
Chunk 18
---
 following table, that the Selling Stockholders will sell all of the shares of Common Stock owned beneficially by it that are covered by this prospectus, but will not sell any other shares of Common Stock that they presently own. Except as set forth below, the Selling Stockholders have not held any position or office, or have otherwise had a material relationship, with us or any of our subsidiaries within the past three years other than as a result of the ownership of our shares of Common Stock or other securities.

| Name of Selling Stockholders |     | Shares Owned prior to Offering |           |    |     | Shares Offered by this Prospectus |           |     | Shares Owned after Offering |   |     | Percentage of Shares Beneficially Owned after Offering 
 (1)                                                    |   |
| Thesprogen, PC               |     |                                |   337,079 | -2 |     |                                   |   337,079 |     |                             | 0 |     |                                                        | * |
| Sarborg Limited              |     |                                | 1,853,933 | -3 |     |                                   | 1,853,933 |     |                             | 0 |     |                                                        | * |

* Less than 1.0%.

| (1) | Percentages                                                                                                                         
 are based on 11,338,523 shares of Common Stock outstanding as of April 21, 2025, assuming the resale of all of the shares of Common 
 Stock covered by this prospectus.                                                                                                   |
| (2) | Consists                                                                                                                            
 of 337,079 shares of Common Stock issued pursuant to the Consulting Agreement.                                                      |
| (3) | Consists                                                                                                                            
 of 1,853,933 shares issued pursuant to the Additional Agreement.                                                                    |

| 14 |

<div align='center'>DESCRIPTION OF COMMON STOCK</div>

The following is a description of our securities of as set forth in certain provisions of our Second Amended and Restated Certificate of Incorporation (the “Charter”) and our Amended and Restated Bylaws (the “Bylaws”), each previously filed with the SEC and incorporated by reference as an exhibit to this registration statement. This summary does not purport to be complete and is qualified in its entirety by the full text of the Charter, Bylaws, and the applicable provisions of the Delaware General Corporation Law (the “DGCL”). We encourage you to read our Charter, Bylaws, and the applicable portions of the DGCL carefully,